Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Choy

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Gastroenterology|April 30, 2026
Reply to TakefujiChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
Inflammatory Bowel Diseases|April 24, 2024
Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case ReportSimone Chin, Lucy Fox, Avik Majumdar, et al.
Gastroenterology|February 25, 2026
Reply to Bourgonje and MianChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
Inflammatory Bowel Diseases|September 19, 2023
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative ColitisChristopher F D Li Wai Suen, Dean Seah, Matthew C Choy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 28, 2020
Tofacitinib Is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative ColitisRobert Gilmore, Patrick Hilley, Ashish Srinivasan, et al.
Inflammatory Bowel Diseases|March 15, 2022
Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver TransplantAdam R Peterson, Ashish Srinivasan, David Proud, et al.
Alimentary Pharmacology & Therapeutics|July 15, 2025
Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver TransplantationSimone Chin, Danny Con, Patrick Hilley, et al.
Alimentary Pharmacology & Therapeutics|August 18, 2025
Editorial: Redefining Safety in Post-Liver Transplant IBD-Why Therapeutic Effectiveness Is the Ultimate Shield. Authors' ReplySimone Chin, Danny Con, Patrick Hilley, et al.
Journal of Gastroenterology and Hepatology|June 16, 2017
Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitisDean Seah, Matthew C Choy, Alexandra Gorelik, et al.
Digestive Diseases and Sciences|March 2, 2026
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency DepartmentChristopher F D Li Wai Suen, Shipraa Kaul, Ethan X Z Tan, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Gastroenterology|April 30, 2026
Reply to TakefujiChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
Inflammatory Bowel Diseases|April 24, 2024
Pneumocystis jirovecii Pneumonia Complicating Use of Upadacitinib in a Patient With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Case ReportSimone Chin, Lucy Fox, Avik Majumdar, et al.
Gastroenterology|February 25, 2026
Reply to Bourgonje and MianChristopher F D Li Wai Suen, Danny Con, Matthew C Choy, et al.
Inflammatory Bowel Diseases|September 19, 2023
Factors Associated With Response to Rescue Therapy in Acute Severe Ulcerative ColitisChristopher F D Li Wai Suen, Dean Seah, Matthew C Choy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 28, 2020
Tofacitinib Is Safe and Effective When Used in Combination With Infliximab for the Management of Refractory Ulcerative ColitisRobert Gilmore, Patrick Hilley, Ashish Srinivasan, et al.
Inflammatory Bowel Diseases|March 15, 2022
Synchronous Multifocal Adenomatous Dysplasia and Post-transplant Lymphoproliferative Disorder Confined to the Colon in a Patient with Ulcerative Colitis After Liver TransplantAdam R Peterson, Ashish Srinivasan, David Proud, et al.
Alimentary Pharmacology & Therapeutics|July 15, 2025
Systemic Biologics Have Similar Safety to Vedolizumab in Inflammatory Bowel Disease Patients Following Liver TransplantationSimone Chin, Danny Con, Patrick Hilley, et al.
Alimentary Pharmacology & Therapeutics|August 18, 2025
Editorial: Redefining Safety in Post-Liver Transplant IBD-Why Therapeutic Effectiveness Is the Ultimate Shield. Authors' ReplySimone Chin, Danny Con, Patrick Hilley, et al.
Journal of Gastroenterology and Hepatology|June 16, 2017
Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitisDean Seah, Matthew C Choy, Alexandra Gorelik, et al.
Digestive Diseases and Sciences|March 2, 2026
Monocyte Distribution Width Differentiates Bacterial Enterocolitis from Acute Severe Ulcerative Colitis in the Emergency DepartmentChristopher F D Li Wai Suen, Shipraa Kaul, Ethan X Z Tan, et al.
Pageof 3